Insulin resistance and sympathetic function in high spinal curd injury

Spinal Cord

Volumn 37, Issue 7, 1999, Pages 494-500

  Karlsson, A K ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adipose tissue; Automic dysreflexia; Insulin resistance; Metabolism; Spinal cord injury; Sympathetic nervous system

Indexed keywords

GLUCOSE; INSULIN; NORADRENALIN;

ADIPOSE TISSUE; ADRENERGIC STIMULATION; ADULT; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEART RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERINSULINEMIA; INSULIN RESISTANCE; ISOTOPE DILUTION ASSAY; ISOTOPE LABELING; LIPOLYSIS; MALE; METABOLIC DISORDER; MICRODIALYSIS; MUSCLE BLOOD FLOW; NORADRENALIN BLOOD LEVEL; ORAL GLUCOSE TOLERANCE TEST; PATIENT MONITORING; PRIORITY JOURNAL; SENSORY NERVE CONDUCTION; SIBLING; SKIN BLOOD FLOW; SPINAL CORD INJURY; SYMPATHETIC FUNCTION; TISSUE METABOLISM; VASOCONSTRICTION;

EID: 0032791780     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100844     Document Type: Article

References (64)

1. 1 Geisler WO et al. Survival in traumatic spinal cord injury. Paraplegia 1983; 21: 364-373.
2. 2 Whiteneck GG et al. Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago. Paraplegia 1992; 30: 617-630.
3. 3 Hartkopp A et al. Survival and causes of death after traumatical spinal cord injury. A long term epidemiological survey from Denmark. Spinal Cord 1997; 35: 76-85.
4. 4 Breithaupt D, Jousse A, Wynne-Jones M. Late causes of death and life expectancy in paraplegia. CMAJ 1961; 85: 73-77.
5. 5 Krause JS, Kjorsvig JM. Mortality after spinal cord injury: a four-year prospective study [published erratum appears in Arch Phys Med Rehabil 1992; 73(8): 716]. Arch Phys Med Rehabil 1992; 73: 558-563.
6. 6 DeVivo MJ, Black KJ, Stover SL. Causes of death during the first 12 years after spinal cord injury. Arch Phys Med Rehabil 1993; 74: 248-254.
7. 7 Yekutiel M et al. The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia 1989; 27: 58-62.
8. 8 Bauman WA et al. Coronary artery disease: metabolic risk factors and latent disease in individuals with paraplegia. Mt Sinai J Med 1992; 59: 163-168.
9. 9 Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
10. 10 Duckworth WC et al. Glucose intolerance due to insulin resistance in patients with spinal cord injuries. Diabetes 1980; 29: 906-910.
11. 11 Bauman WA, Spungen AM. Disorders of carbohydrate and lipid metabolism in veterans with paraplegia or quadriplegia: a model of premature aging. Metabolism 1994; 43: 749-756.
12. 12 Levi R, Hultling C, Seiger A. The Stockholm Spinal Cord Injury Study. 3. Health-related issues of the Swedish annual level-of-living survey in SCI subjects and controls. Paraplegia 1995; 33: 726-730.
13. 13 Spungen AM et al. Measurement of body fat in individuals with tetraplegia: a comparison of eight clinical methods. Paraplegia 1995; 33: 402-408.
14. 14 Seherrer U et al. Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634-2640.
15. 15 Spraul M et al. Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 1993; 92: 1730-1735.
16. 16 Berne C, Fagius J, Niklasson F, Sympathetic response to oral carbohydrate administration. Evidence from microelectrode nerve recordings. J Clin Invest 1989; 84: 1403-1409.
17. 17 Heseltine D et al. Blood pressure, heart rate and neuroendocrine responses to a high carbohydrate and a high fat meal in healthy young subjects. Clin Sci Colch 1990; 79: 517-522.
18. 18 Rowe JW et al. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30: 219-225.
19. 19 Anderson EA et al. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991; 87: 2246-2252.
20. 20 Berne C et al. The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992; 35: 873-897.
21. 21 Lager I et al. Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of beta 2-receptors. Diabetologia 1986; 29: 409-416.
22. 22 Mathias CJ et al. Physiological responses to insulin hypoglycaemia in spinal man. Paraplegia 1979; 17: 319-326.
23. 23 Palmer JP et al. Glucagon response to hypoglycemia in sympathectomized man. J Clin Invest 1976; 57: 522-525.
24. 24 Corbett JL, Frankel HL, Harris PJ. Cardiovascular reflex responses to cutaneous and visceral stimuli in spinal man. J Physiol Lond 1971; 215: 395-409.
25. 25 Guttman L, Whitteridge D. Effects on bladder distension on autonomic mechanisms after spinal cord injuries. Brain 1949; 70: 361-405.
26. 26 Kewalramani LS. Autonomic dysreflexia in traumatic myclopathy. Am J Phys Med 1980; 59: 1-21.
27. 27 Mathias CJ et al. Plasma catecholamines during paroxysmal neurogenic hypertension in quadriplegic man. Circ Res 1976; 39: 204-208.
28. 28 Harvey RF et al. Catecholamine metabolites in spinal cord injury. Arch Phys Med Rehabil 1982; 63: 419-422.
29. 29 Stjernberg L, Blumberg H, Wallin BG. Sympathetic activity in man after spinal cord injury. Outflow to muscle below the lesion. Brain 1986; 109: 695-715.
30. 30 Wallin BG, Stjernberg L. Sympathetic activity in man after spinal cord injury. Outflow to skin below the lesion. Brain 1984; 107: 183-198.
31. 31 Esler M. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990; 70: 963-985.
32. 32 Eisenhofer G et al. Neuronal uptake, metabolism, and release of tritium-labeled norepinephrine during assessment of its plasma kientics. Am J Physiol 1991; 261: E505-E515.
33. 33 Mathias CJ, Frankel HL, Bannister R, Mathias CJ, (eds). Autonomic disturbances in spinal cord lesions. In: Autonomic failure. 2nd edn. Oxford University Press. 1992; 839-881.
34. 34 Normell LA. Distribution of impaired cutaneous vasomotor and sudomotor function in paraplegic man. Scand J Clin Lab Invest 1974; 138: 25-41.
35. 35 Karlsson AK et al. Influence of the sympathetic nervous system on insulin sensitivity and adipose tissue metabolism: a study in spinal cord-injured subjects. Metabolism 1995; 44: 52-58.
36. 36 Mazess RB, Peppler WW, Gibbons M. Total body composition by dual-photon (153Gd) absorptiometry. Am J Clin Nutr 1984; 40: 834-839.
37. 37 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214-E223.
38. 38 Lonnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans. Am J Physiol 1987; 253: E228-E231.
39. 39 Larsen OA, Lassen NA, Quaade F. Blood flow through human adipose tissue determined with radioactive xenon. Acta Physiol Scand 1996; 66: 337-345.
40. 40 Karlsson AK et al. Regulation of lipolysis by sympathetic nervous system. A microdialysis study in normal and spinal cord injured subjects. Metabolism 1997; 46: 388-394.
41. 41 Karlsson AK et al. Peripheral afferent stimulation of decentralised sympathetic neurones activates lipolysis in spinal cord injured subjects. Metabolism 1997; 46: 1465-1469.
42. 42 Jacobsson B, Smith U. Effect of cell size on lipolysis and antilipolytic action of insulin in human fat cells. J Lipid Res 1972; 13: 651-656.
43. 43 Esler M et al. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 1979; 25: 1461-1470.
44. 44 Karlsson AK et al. Differentiated norpinephrine spillover in human skeletal muscle. Am J Physiol 1997; 273: R16-R21.
45. 45 Kowarski A et al. Determination of integrated plasma concentrations and true secretion rates of human growth hormone. J Clin Endocrinol Metab 1971; 32: 356-160.
46. 46 Burnham R et al. Intentional induction of autonomic dysreflexia among quadriplegic athletes for performance enhancement; efficiacy, safety and mechanisms of action. Clin J Sport Med 1994; 4: 1-10.
47. 47 Wheeler G et al. Testosterone, cortisol and catecholamine responses to exercise stress and autonomic dysreflexia in elite quadriplegic athletes [see comments]. Paraplegia 1994; 32: 292-299.
48. 48 Larsson B et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J Clin Res Ed 1984; 288: 1401-1404.
49. 49 Grimby G, Kvist H, Grangard U. Reduction in thigh muscle cross-sectional area and strength in a 4-year follow-up in late polio. Arch Phys Med Rehabil 1996; 77: 1044-1048.
50. 50 Cousin B et al. Local sympathetic denervation of white adipose tissue in rats induces preadipocyte proliferation without noticeable changes in metabolism. Endocrinology 1993; 133: 2255-2262.
51. 51 Attvall S et al. Early posthypoglycemic insulin resistance in man is mainly an effect of beta-adrenergic stimulation. J Clin Invest 1987; 80: 437-442.
52. 52 Aksnes AK et al. Intact glucose transport in morphologically altered denervated skeletal muscle from quadriplegic patients. Am J Physiol 1996; 271: E593-E600.
53. 53 Krotkiewski M, Bjorntorp P. Muscle tissue in obesity with different distribution of adipose tissue. Effects of physical training. Int J Obes 1986; 10: 331-341.
54. 54 Chang PC, van der Krogt JA, van Brummelen P. Demonstration of neuronal and extraneural uptake of circulating norepinephrine in the forearm. Hypertension 1987; 9: 647-653.
55. 55 Yamaguchi N, de Champlain J, Nadeau RA. Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic alpha-and beta-receptors. Circ Res 1977; 41: 108-117.
56. 56 Mathias CJ et al. Enhanced pressor response to noradrenaline in patients with cervical spinal cord transection. Brain 1976; 99: 757-770.
57. 57 Norberg KA, Normell LA. Histochemical demonstration of sympathetic adrenergic denervation in human skin. Acta Neurol Scand 1974; 50: 261-271.
58. 58 Davies IB et al. Agonist regulation of alpha-adrenergic receptor responses in man. J Cardiovasc Pharmacol 1982; 4: S139-S144.
59. 59 Maiorov DN, Weaver LC, Krassioukov AV. Relationship between sympathetic activity and arterial pressure in conscious spinal rats. Am J Physiol 1997; 272: H625-H631.
60. 60 Krassioukov AV, Weaver LC. Morphological changes in sympathetic preganglionic neurons after spinal cord injury in rats. Neuroscience 1996; 70: 211-225.
61. 61 Krassioukov AV, Weaver LC. Reflex and morphological changes in spinal preganglionic neurons after cord injury in rats. Clin Exp Hypertens 1995; 17: 361-373.
62. 62 Krum H et al. Steady stae plasma [3H]-noradrenaline kinetics in quadriplegic chronic spinal cord injury patients. J Auton Pharmacol 1990; 10: 221-226.
63. 63 Eisenhofer G et al. Regional release and removal of catecholamines and extraneuronal metabolism to metanephrines. J Clin Endocrinol Metab 1995; 80: 3009-3017.
64. 64 Esler M et al. Contribution of individual organs to total noradrenaline release in humans. Acta Physiol Scand Suppl 1984; 527: 11-16.